I mean, that is a remarkable figure. Today we're going to be talking about the update to the list. There's some good news. I'm happy to report that DHS management has made solid progress and there's some prospects of DHS coming off [the high risk] list. We're looking forward to that. There's been progress made in terms of Department of Defense contract management, progress made with FDA's oversight of medical devices. (00:46)
CLAIM
Asserts that DHS management improvements may lead to removal from the high-risk list.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.